109 related articles for article (PubMed ID: 1487834)
1. Vancomycin kinetics in plasma and synovial fluid following intravenous administration in horses.
Orsini JA; Ramberg CF; Benson CE; Dreyfuss DJ; Vecchione JA; Kunz CC
J Vet Pharmacol Ther; 1992 Dec; 15(4):351-63. PubMed ID: 1487834
[TBL] [Abstract][Full Text] [Related]
2. Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses.
Orsini JA; Moate PJ; Engiles J; Norman T; Poppenga R; Benson CE; Boston RC
J Vet Pharmacol Ther; 2004 Oct; 27(5):293-8. PubMed ID: 15500566
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of safety and pharmacokinetics of vancomycin after intravenous regional limb perfusion in horses.
Rubio-Martínez LM; López-Sanromán J; Cruz AM; Santos M; Andrés MS; Román FS
Am J Vet Res; 2005 Dec; 66(12):2107-13. PubMed ID: 16379655
[TBL] [Abstract][Full Text] [Related]
4. Medullary plasma pharmacokinetics of vancomycin after intravenous and intraosseous perfusion of the proximal phalanx in horses.
Rubio-Martínez L; López-Sanromán J; Cruz AM; Santos M; San Román F
Vet Surg; 2005; 34(6):618-24. PubMed ID: 16343150
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of safety and pharmacokinetics of vancomycin after intraosseous regional limb perfusion and comparison of results with those obtained after intravenous regional limb perfusion in horses.
Rubio-Martínez LM; López-Sanromán J; Cruz AM; Tendillo F; Rioja E; San Román F
Am J Vet Res; 2006 Oct; 67(10):1701-7. PubMed ID: 17014319
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intraosseous or intravenous infusion for delivery of amikacin sulfate to the tibiotarsal joint of horses.
Scheuch BC; Van Hoogmoed LM; Wilson WD; Snyder JR; MacDonald MH; Watson ZE; Steffey EP
Am J Vet Res; 2002 Mar; 63(3):374-80. PubMed ID: 11911572
[TBL] [Abstract][Full Text] [Related]
7. Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.
Uney K; Altan F; Altan S; Erol H; Arican M; Elmas M
J Vet Pharmacol Ther; 2017 Jun; 40(3):239-247. PubMed ID: 27641837
[TBL] [Abstract][Full Text] [Related]
8. Bone gentamicin concentration after intra-articular injection or regional intravenous perfusion in the horse.
Werner LA; Hardy J; Bertone AL
Vet Surg; 2003; 32(6):559-65. PubMed ID: 14648535
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of imipenem-cilastatin following intravenous administration in healthy adult horses.
Orsini JA; Moate PJ; Boston RC; Norman T; Engiles J; Benson CE; Poppenga R
J Vet Pharmacol Ther; 2005 Aug; 28(4):355-61. PubMed ID: 16050815
[TBL] [Abstract][Full Text] [Related]
10. Serum and synovial fluid steady-state concentrations of trimethoprim and sulfadiazine in horses with experimentally induced infectious arthritis.
Bertone AL; Jones RL; McIlwraith CW
Am J Vet Res; 1988 Oct; 49(10):1681-7. PubMed ID: 3189982
[TBL] [Abstract][Full Text] [Related]
11. Serum and Synovial Vancomycin Concentrations in Patients with Prosthetic Joint Infection after Intra-articular Infusion.
He JW; Wang J; Cao L; Zhang XG; Li GQ; Xu BY; Ji BC; Ge SY; Yang JH
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):637-643. PubMed ID: 34275127
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
14. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
[TBL] [Abstract][Full Text] [Related]
16. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
Ploessl C; White C; Manasco K
Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
18. Bacterial culture of septic synovial structures of horses: does a positive bacterial culture influence prognosis?
Taylor AH; Mair TS; Smith LJ; Perkins JD
Equine Vet J; 2010 Apr; 42(3):213-8. PubMed ID: 20486977
[TBL] [Abstract][Full Text] [Related]
19. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
